Year : 2021 | Volume
: 7 | Issue : 2 | Page : 145-
Erratum: Risk factors for focal osteolysis in a stainless-steel limb-lengthening device
|How to cite this article:|
. Erratum: Risk factors for focal osteolysis in a stainless-steel limb-lengthening device.J Limb Lengthen Reconstr 2021;7:145-145
|How to cite this URL:|
. Erratum: Risk factors for focal osteolysis in a stainless-steel limb-lengthening device. J Limb Lengthen Reconstr [serial online] 2021 [cited 2022 Jul 3 ];7:145-145
Available from: https://www.jlimblengthrecon.org/text.asp?2021/7/2/145/335951
In the article titled “Risk factors for focal osteolysis in a stainless-steel limb-lengthening device”, published on pages 19-25, Issue 1, Volume 7 in Journal of Limb Lengthening & Reconstruction, the following paragraph was missing under the section Financial support and sponsorship.
JDC is a consultant for Bonesupport, Orthofix, Smith+Nephew, and Zimmer Biomet, receives fellowship support from Biocomposites, is on the MicroGenDX Advisory Board, and her spouse receives royalties from the University of Florida. SCS is a consultant for NuVasive Specialized Orthopedics and Smith+Nephew, and receives royalties from NuVasive Specialized Orthopedics, Pega Medical, and Smith+Nephew. MA is an unpaid consultant for Johnson & Johnson, OrthoPediatrics, and Orthofix. JEH is a clinical advisor for Bonus BioGroup and a consultant for NuVasive Specialized Orthopedics, Orthofix, OrthoPediatrics, OrthoSpin, Smith+Nephew, and WishBone Medical. PKM is a consultant for DePuy Synthes Companies, Novadip, Orthofix, and Smith+Nephew. The following organizations supported the institution of OCS, JDC, SCS, MA, JEH, and PKM: Biocomposites, DePuy Synthes Companies, MHE Coalition, Orthofix, OrthoPediatrics, Pega Medical, Smith+Nephew, Stryker, and Zimmer Biomet.